JG
AMAG

Jefferies Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Jefferies Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-38,200
Closed -$465K – 2887
2019
Q4 		$465K Buy
38,200
+700
+2% +$7.65K ﹤0.01% 1858
2019
Q3 		$433K Buy
+37,500
New +$395K ﹤0.01% 1961
2015
Q4 		– Sell
-6,000
Closed -$238K – 2668
2015
Q3 		$238K Sell
6,000
-21,000
-78% -$1.3M ﹤0.01% 1868
2015
Q2 		$1.86M Buy
+27,000
New +$1.7M 0.01% 947

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jefferies Group's AMAG Position: Q3 2019 in Review

Jefferies Group sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 18,275 shares — an estimated $192K sold.

Jefferies Group first reported a position in AMAG in Q3 2014 and held it in 9 quarters. The position peaked at $3M in Q4 2014. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Jefferies Group reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 18,275 AMAG Pharmaceuticals shares in Q3 2019, an estimated $192K.
  • Jefferies Group first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 9 quarters.
  • Jefferies Group's AMAG Pharmaceuticals position peaked at $3M in Q4 2014.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.